Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients

被引：5
作者：
Meszaros, K
Lenzinger, E
Hornik, K
Schonbeck, G
Hatzinger, R
Langer, G
Sieghart, W
Aschauer, HN
机构：
[1] UNIV VIENNA, HOSP PSYCHIAT, DEPT GEN PSYCHIAT, VIENNA, AUSTRIA
[2] VIENNA UNIV ECON, DEPT STAT, VIENNA, AUSTRIA
[3] VIENNA TECH UNIV, INST STAT & WAHRSCHEINLICHKEITSTHEORIE, VIENNA, AUSTRIA
来源：
NEUROPSYCHOBIOLOGY | 1997年 / 36卷 / 02期
关键词：
biperiden plasma levels; haloperidol plasma levels; relation between dose and plasma levels; extrapyramidal side effects; chronic schizophrenia;
D O I：
10.1159/000119365
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Anticholinergic drugs such as biperiden are used for the treatment of extrapyramidal side effects (EPS) induced by neuroleptics such as haloperidol. The effects of biperiden and haloperidol plasma levels on EPS were studied in 29 chronically ill schizophrenics. The results show relationships between biperiden dose and biperiden plasma levels (BPL), and between BPL and haloperidol plasma levels (HPL). Neither BPL nor HPL seem to influence EPS.
引用
收藏
页码：69 / 72
页数：4
相关论文
共 50 条
[31]   Clozapine versus typical antipsychotics - A retro- and prospective study of extrapyramidal side effects [J].
Peacock, L ;
Solgaard, T ;
Lublin, H ;
Gerlach, J .
PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :188-196
[32]   Cross-sectional examination of extrapyramidal side effects in a specialist palliative care inpatient unit [J].
O'Brien, Hannah ;
Kiely, Fiona ;
Barry, Aileen ;
Meaney, Sarah .
BMJ SUPPORTIVE & PALLIATIVE CARE, 2019, 9 (03) :271-273
[33]   Extrapyramidal side-effects of low-dose aripiprazole in an 11-year-old child [J].
Mohapatra, Satyakam .
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2016, 7 (01) :141-+
[34]   Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth [J].
Pringsheim, Tamara ;
Doja, Asif ;
Belanger, Stacey ;
Patten, Scott .
PAEDIATRICS & CHILD HEALTH, 2011, 16 (09) :590-598
[35]   Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D2 receptor occupancy [J].
Yamada, Y ;
Ohno, Y ;
Nakashima, Y ;
Fukuda, M ;
Takayanagi, R ;
Sato, H ;
Tsuchiya, F ;
Sawada, Y ;
Iga, T .
SYNAPSE, 2002, 46 (01) :32-37
[36]   Association of MTHFR 677C > T genetic polymorphism with extrapyramidal side effects of antipsychotic treatment [J].
Zhilyaeva, T. V. ;
Akimova, E. V. ;
Sergeeva, A. V. ;
Blagonravova, A. S. ;
Mazo, G. E. .
GENE REPORTS, 2020, 20
[37]   D-2 RECEPTOR BLOCKADE BY FLUNARIZINE AND CINNARIZINE EXPLAINS EXTRAPYRAMIDAL SIDE-EFFECTS - A SPECT STUDY [J].
BRUCKE, T ;
WOBER, C ;
PODREKA, I ;
WOBERBINGOL, C ;
ASENBAUM, S ;
AULL, S ;
WENGER, S ;
ILIEVA, D ;
HARASKOVANDERMEER, C ;
WESSELY, P ;
DEECKE, L .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (03) :513-518
[38]   An animal model of extrapyramidal side effects induced by antipsychotic drugs: Relationship with D2 dopamine receptor occupancy [J].
Crocker, AD ;
Hemsley, KM .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (03) :573-590
[39]   D-2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: A pilot study with sertindole in healthy subjects [J].
Farde, L ;
Mack, RJ ;
Nyberg, S ;
Halldin, C .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 :S3-S7
[40]   Case series: Spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia [J].
Kumra, S ;
Jacobsen, LK ;
Lenane, M ;
Smith, A ;
Lee, P ;
Malanga, CJ ;
Karp, BI ;
Hamburger, S ;
Rapoport, JL .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (02) :221-227
12345